GILDBiotech
FollowFollowingUnfollowFree · no card
Get what investors say about GILD next
2 new calls on GILD this week are not on this page yet. Follow GILD free and new calls come to you in The Brief, our morning email, the day after we record them. This page shows them a week later.
or continue with Google ·
Who said what, and what GILD did next
Every dot is a day someone on the record made a call. Hover one to see who. We are not scoring them — the point is that you can see it and judge for yourself.
Who’s talking about GILD
| Date | Voice | Stance | Venue | Thesis |
|---|---|---|---|---|
| 2026-10-26 | Jeff Meechum | Bullish | CNBC (uncut) | Gilead's HIV prevention drug YesTUGO is performing well and a next-gen blood cancer drug launching year-end… |
| 2026-08-04 | Rob Sechan (NewEdge Wealth)Co-founder & CEO, NewEdge Wealth | Bullish | CNBC Halftime Final Trades | Gilead trades at only 16x earnings despite owning one of the best oncology franchises and Biktarvy, the… |
| 2025-07-18 | Jc ParetsFounder & Chief Market Strategist, All Star Charts | Bullish | The Compound | Gilead is breaking out to multi-year highs after 15 years of going nowhere, making it one of only two top-10… |
| 2022-08-19 | Kevin O LearyChairman, O'Leary Ventures | Bullish | CNBC Halftime Committee | Gilead's 4.5% dividend is supported by a deep pipeline across cell therapy, HIV, and oncology, and the… |
| 2017-11-02 | Tobias CarlisleFounder & CIO, Acquirers Funds | Bullish | Meb Faber | Gilead had fallen ~50% from its peak and was trading at roughly 3x acquirer's multiple with a 'lazy'… |
Last reports
| Report | When | EPS actual vs est. | Reaction |
|---|---|---|---|
| 29 Oct 2026 | after the close | 2.55 vs 2.23 | -7.8% |
Notable options days
Sessions in the last 120 where GILD’s settled options volume ran ≥ 2× its trailing 20-session baseline, or delta-dollar flow ran ≥ 2.5× — 9 of 120 sessions qualified.
| Date | Close | RVOL | Δ$ flow ($M) | Call % | LEAPS % | +20 sess. |
|---|---|---|---|---|---|---|
| 2026-10-29 | ||||||
| 2026-10-27 | ||||||
| 2026-10-16 | ||||||
| 2026-10-15 | ||||||
| 2026-09-14 | ||||||
| 2026-08-11 | ||||||
| 2026-08-05 | ||||||
| 2026-08-04 | ||||||
| 2026-06-11 |
GILD on the Wheel
GILD did not pass our 1-month put test (V3); the Wheel shows its puts without calling one best.
The Wheel lists cash-secured puts on stocks after a 3% drop, with live quotes, the chance of assignment and each stock’s own history. Free to use; a free account lets you follow stocks, add your own and ask questions.
Decision support, not advice · questions put sellers ask us
Idea Scout
Following GILD? Every Sunday we read the tape so you don't have to — who's recommending what, where they agree, and who just changed their mind. One free email a week.
Free · double opt-in · unsubscribe in one click